Melanie NallicheriHOW EQRx IS ADDRESSING FINANCIAL TOXICITYOver the past several weeks, EQRx has announced positive results from two Phase 3 studies for our late-stage therapies — our EGFR…Jun 16, 2021Jun 16, 2021
Melanie NallicheriTo Reduce Prescription Drug Prices, Assemble a Team of Unlikely AlliesIn December, Pfizer and Moderna became the first companies to receive emergency authorization for their COVID-19 vaccines. Though this…Jan 28, 20212Jan 28, 20212